Edwards Lifesciences EW
NYSE EW
$88.08 +1.25 (+1.44%)
As of: Sep 29, 2026 · 3:59 PM EDT

Edwards Lifesciences (EW) Income from Continuing Operations (2009 - 2026)

Updated

Edwards Lifesciences' Income from Continuing Operations was $241.4 million in Q2 2026, down 28.1% from $335.9 million a year earlier and down 36.6% from the prior quarter.

Analysis

Edwards Lifesciences (EW) Income from Continuing Operations (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Edwards Lifesciences' Income from Continuing Operations was $979.4 million through Jun 30, 2026, down 30.5% year-over-year; for FY2025, it was $1.06 billion, down 24.3% from FY2024.

  • Income from Continuing Operations shows a five-year compound annual growth rate of 5.2% (FY2020 to FY2025).
  • In earlier years, Income from Continuing Operations was $1.4 billion in FY2024 (+14.5%), $1.22 billion in FY2023 (-7.6%), $1.32 billion in FY2022 (-11.9%) and $1.5 billion in FY2021 (+82.5%).
  • Quarterly Income from Continuing Operations has moved between $64.2 million (Q4 2025) and $406.4 million (Q2 2022) over five years.
  • Compared with a year earlier, Income from Continuing Operations was higher in four of the last eight quarters, with an average decline of 13.6%.
  • The best year-over-year quarter for Income from Continuing Operations over five years was Q4 2023 (growth of 66.1%); the worst was Q4 2025 (a decline of 81.4%).
  • Per Business Quant data, EW's Income from Continuing Operations in the three quarters before Q2 2026 was $380.7 million (Q1 2026), $64.2 million (Q4 2025) and $293.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 1.76 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 928.00 Mn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 870.00 Mn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 823.20 Mn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 1.48 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn -220.00 Mn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 905.00 Mn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 451.00 Mn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 241.40 Mn
10 Agilent Technologies 49.40 Bn 42.29 Bn 1.04 Bn 362.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 241.40 Mn
Mar 31, 2026 380.70 Mn
Dec 31, 2025 64.20 Mn
Sep 30, 2025 293.10 Mn
Jun 30, 2025 335.90 Mn
Mar 31, 2025 365.20 Mn
Dec 31, 2024 345.00 Mn
Sep 30, 2024 363.50 Mn
Jun 30, 2024 365.30 Mn
Mar 31, 2024 325.80 Mn
Dec 31, 2023 333.10 Mn
Sep 30, 2023 334.90 Mn
Jun 30, 2023 251.40 Mn
Mar 31, 2023 300.60 Mn
Dec 31, 2022 200.50 Mn
Sep 30, 2022 343.50 Mn
Jun 30, 2022 406.40 Mn
Mar 31, 2022 373.60 Mn
Dec 31, 2021 335.30 Mn
Sep 30, 2021 340.10 Mn
API Access

Edwards Lifesciences Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=EW&period=max&api_key=YOUR_API_KEY